CG Oncology, Inc. (CGON) vs Oruka Therapeutics, Inc. (ORKA)
CG Oncology, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. CG Oncology, Inc. and Oruka Therapeutics, Inc. are of similar size ($6.1B and $5.7B). Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −3,602.7%) and the higher return on invested capital (−40.2% vs −4,111.6%). Across the 14 metrics below, Oruka Therapeutics, Inc. leads on 14 and CG Oncology, Inc. on 0.
Valuation
Profitability
| Metric | CGON | ORKA | Biotechnology median |
|---|---|---|---|
| Gross margin | (85.20%) | 0.00% | 65.16% |
| Operating margin | (4,056.18%) | 0.00% | 0.00% |
| Net margin | (3,602.68%) | 0.00% | 0.00% |
| Free cash flow margin | (2,879.62%) | 0.00% | 0.00% |
| Return on equity | (26.41%) | (18.30%) | (57.72%) |
| Return on assets | (25.11%) | (17.76%) | (49.22%) |
| Return on invested capital | (4,111.64%) | (40.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack